Radiopharm Theranostics 주식 가격. RADX - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

가격

4.64

매수가

4.50

매도가

5.46

거래량

20,444

4.64 일간 변동폭 5.085

0.00 52주 범위 0.00

전일 종가

4.75

개장가

5.00

최근 거래 시간

4.96

마지막 거래 시간

평균 볼륨(3m)

재정 규모

US$ 97,575

VWAP

4.7728

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Lantheus Increases to 12.16% shareholding in Radiopharm with US$5m (A$8m) Placement

Private placement to radiopharmaceutical industry leader Lantheus, for US$5.0 millionPlacement at A$0.060 per share, representing a premium of 150% to the last closing price of A$0.024Lantheus...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

RAD to advance the clinical development of Lantheus innovative radiopharmaceuticals in Australia Initial collaboration will focus on a Phase 1 imaging trialFinancial incentives to be paid to RAD...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Ethics approval received in Australia for the initiation of RAD’s Phase 1 therapeutic trial of 177Lu-RAD202 in Breast and Gastric CancersThe Phase 1 First-In-Human study is designed to assess the...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form EFFECT - Notice of Effectiveness

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

RADX - Frequently Asked Questions (FAQ)

What is the current Radiopharm Theranostics share price?

The current share price of Radiopharm Theranostics is US$ 4.64

What is the 1 year trading range for Radiopharm Theranostics share price?

Radiopharm Theranostics has traded in the range of US$ 0.00 to US$ 0.00 during the past year

가장 활성
% 상승자
% 패자

기호	가격	볼륨
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	731.1M
REBNReborn Coffee Inc	US$ 3.31 (63.05%)	55.54M
FCUVFocus Universal Inc	US$ 5.87 (56.62%)	1.73M
SOPASociety Pass Inc	US$ 1.54 (56.50%)	13.87M
CYCNCyclerion Therapeutics Inc	US$ 3.92 (54.33%)	82.57M
ENVBEnveric Biosciences Inc	US$ 2.0899 (-46.41%)	1.57M
NIVFNewGenIvf Group Ltd	US$ 0.1489 (-42.51%)	14.8M
GLSTGlobal Star Acquisition Inc	US$ 8.83 (-39.10%)	23.89k
PRPHProPhase Labs Inc	US$ 0.2633 (-38.02%)	872.46k
SPGCSacks Parente Golf Inc	US$ 0.5601 (-37.86%)	7.27M
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	731.1M
NVDANVIDIA Corporation	US$ 120.07 (-3.67%)	388.5M
RIMEAlgorhythm Holdings Inc	US$ 0.02565 (5.12%)	341.8M
CLEUChina Liberal Education Holdings Ltd	US$ 0.1938 (30.77%)	237.15M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0355 (-11.25%)	236.44M

Invest-in-America 2 월 전

RADX: Whelp, for what it's worth, here's the new RADX iHub BOARD!!!! (They make cute DIAGNOSTIC --- & potentially THERAPEUTIC, as well --- Medical gadgets that can enter tiny, obscure, sites in our Homo sapiens BODIES; and then hopefully determine what-the-heck bad things are transpiring in there, & maybe fix them to boot!!!)

👍️0

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Radiopharm Theranostics Ltd (RADX)

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

RADX 최신 뉴스

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Lantheus Increases to 12.16% shareholding in Radiopharm with US$5m (A$8m) Placement

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form EFFECT - Notice of Effectiveness

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Lantheus Increases to 12.16% shareholding in Radiopharm with US$5m (A$8m) Placement

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

RADX - Frequently Asked Questions (FAQ)

이동자

RADX Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Radiopharm Theranostics Ltd (RADX) 시세

Radiopharm Theranostics Ltd (RADX)

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

RADX 최신 뉴스

RADX - Frequently Asked Questions (FAQ)

이동자

RADX Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기

광고 제거

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR